CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 177 filers reported holding CRINETICS PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,221,385 | +97.6% | 410,941 | +19.7% | 0.00% | +100.0% |
| Q2 2023 | $6,184,086 | +309568.8% | 343,179 | +176.1% | 0.00% | +100.0% |
| Q1 2023 | $1,997 | -20.8% | 124,309 | -9.7% | 0.00% | 0.0% |
| Q4 2022 | $2,520 | -100.0% | 137,693 | -53.6% | 0.00% | -50.0% |
| Q3 2022 | $5,825,000 | -22.3% | 296,591 | -26.2% | 0.00% | -33.3% |
| Q2 2022 | $7,498,000 | +32.8% | 402,010 | +35.3% | 0.00% | +50.0% |
| Q1 2022 | $5,646,000 | -21.1% | 297,125 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $7,160,000 | +159.4% | 295,512 | +144.1% | 0.00% | +100.0% |
| Q3 2021 | $2,760,000 | -1.3% | 121,056 | -18.4% | 0.00% | 0.0% |
| Q2 2021 | $2,796,000 | +41.4% | 148,349 | +14.5% | 0.00% | 0.0% |
| Q1 2021 | $1,978,000 | +2.2% | 129,507 | -5.6% | 0.00% | 0.0% |
| Q4 2020 | $1,935,000 | -31.3% | 137,162 | -23.7% | 0.00% | 0.0% |
| Q3 2020 | $2,815,000 | +2.6% | 179,667 | +14.8% | 0.00% | 0.0% |
| Q2 2020 | $2,744,000 | +564.4% | 156,572 | +458.2% | 0.00% | – |
| Q1 2020 | $413,000 | -41.7% | 28,050 | -0.7% | 0.00% | – |
| Q4 2019 | $709,000 | +65.3% | 28,241 | -1.0% | 0.00% | – |
| Q3 2019 | $429,000 | -42.2% | 28,540 | -3.9% | 0.00% | – |
| Q2 2019 | $742,000 | – | 29,706 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 623,819 | $11,336,501 | 9.41% |
| Finepoint Capital LP | 822,745 | $15,056 | 4.87% |
| Bain Capital Life Sciences Investors, LLC | 2,305,558 | $42,192 | 4.72% |
| Opaleye Management Inc. | 732,000 | $13,395,600 | 4.66% |
| 5AM Venture Management, LLC | 862,286 | $15,779,834 | 4.24% |
| SPHERA FUNDS MANAGEMENT LTD. | 671,644 | $12,291,085 | 2.64% |
| First Light Asset Management, LLC | 1,329,313 | $24,326,428 | 2.26% |
| BRAIDWELL LP | 3,469,674 | $63,495,034 | 2.13% |
| BVF INC/IL | 2,736,613 | $50,080,018 | 2.11% |
| Perceptive Advisors | 4,039,276 | $73,918,751 | 2.08% |